Abemaciclib plus a nonsteroidal aromatase inhibitor as initial therapy for HR+, HER2− advanced breast cancer: final overall survival results of MONARCH 3 ☆
Titel:
Abemaciclib plus a nonsteroidal aromatase inhibitor as initial therapy for HR+, HER2− advanced breast cancer: final overall survival results of MONARCH 3 ☆
Auteur:
Goetz, M.P. Toi, M. Huober, J. Sohn, J. Trédan, O. Park, I.H. Campone, M. Chen, S.-C. Manso, L.M. Paluch-Shimon, S. Freedman, O.C. O’Shaughnessy, J. Pivot, X. Tolaney, S.M. Hurvitz, S.A. Llombart-Cussac, A. André, V. Saha, A. van Hal, G. Shahir, A. Iwata, H. Johnston, S.R.D.